BGM0504
Bioequivalence Study of BGM0504 Injection
BrightGene Bio-Medical Technology Co · Phase 1 · Completed · Enrollment 144
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| BGM0504 Injection multi-dose pen | n/r | n/r | n/r | n/r | n/r |
| BGM0504 Injection single-dose pen | n/r | n/r | n/r | n/r | n/r |
| BGM0504 Injection single-dose pen-2 | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.